Health
Pfizer’s vaccine offers COVID-19 protection after first dose, FDA says – Sydney Morning Herald
Pfizer has cleared the next hurdle in the race to get its COVID-19 vaccine approved for emergency use in the US.
The agency typically follows the recommendations of its advisory panels but is not required to do so.
The good news is that this very important part of the process is playing out just like it should and just like it does with every other FDA regulatory review process, said Dr Helen Boucher, Chief of Infectious Diseases at Tufts Medical Centre, in an interview with Reuters.
Data from the trial showed that the vaccine began conferring some protection to recipients even before they received the second…
-
Noosa News21 hours agoBrisbane vs Collingwood live blog: Richmond selects Noah Balta as unbeaten Lions prepare for Magpies test
-
General20 hours agoNT Coalition candidate Lisa Siebert diverges from Jacinta Nampijinpa Price on royal commission call
-
Noosa News23 hours agoAustralians tell ABC’s Your Say how they saw the second leaders debate
-
General22 hours agoCanberra man named as doctor accused of rape after suppression order lifted